Bedrijfsvoering Silence Therapeutics plc

Aandelen

SLN

US82686Q1013

Biotechnologie & Medisch Onderzoek

Geschatte realtime Cboe BZX 20:03:59 13-02-2025 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
4,185 USD +1,82% Intraday-grafiek van Silence Therapeutics plc -27,48% -39,39%

Uitvoerend comité: Silence Therapeutics plc

Bedrijfsleider
Beklede functiesVan
Craig Tooman

Craig Tooman

59 jaar

Chief Executive Officer 21-02-2022
President 21-02-2022
Marie Wikström Lindholm

Marie Wikström Lindholm

Chief Tech/Sci/R&D Officer 01-12-2023
Linnea Corwin Elrington

Linnea Corwin Elrington

Human Resources Officer 01-11-2017
Steven Romano

Steven Romano

65 jaar

Chief Tech/Sci/R&D Officer 01-04-2023
Gem Hopkins

Gem Hopkins

Investor Relations Contact 01-08-2020
Public Communications Contact 01-08-2020
Rhonda Hellums

Rhonda Hellums

53 jaar

Director of Finance/CFO 21-02-2022
Corporate Secretary -
Eric Floyd

Eric Floyd

62 jaar

General Counsel 01-07-2020
Curtis Rambaran

Curtis Rambaran

Chief Tech/Sci/R&D Officer 01-01-2021

Samenstelling van de raad van bestuur: Silence Therapeutics plc

Directeur
RadenVan
Iain Ross

Iain Ross

72 jaar

Nominating Committee Chair 01-07-2021
Governance Committee Chair 01-07-2021
Craig Tooman

Craig Tooman

59 jaar

Audit Committee 18-08-2020
Compensation Committee
Compensation Committee Chair 18-08-2020
Governance Committee Chair 18-08-2020
Nominating Committee Chair 18-08-2020
James Ede-Golightly

James Ede-Golightly

45 jaar

Audit Committee 25-04-2019
Audit Committee Chair 01-04-2018
Compensation Committee Chair 25-04-2019
Michael Davidson

Michael Davidson

68 jaar

Audit Committee 28-01-2022
Compensation Committee 25-02-2021
David Lemus

David Lemus

62 jaar

Audit Committee Chair 01-01-2020
Compensation Committee 21-06-2018

Voormalige zaakvoerders en bestuurders: Silence Therapeutics plc

Insider
Beklede functies
VanTot
Alistair Gray
Alistair Gray
Director/Board Member 12-11-2015 01-05-2024
Independent Dir/Board Member 12-11-2015 01-05-2024
John Strafford
John Strafford
Corporate Officer/Principal 01-05-2019 01-04-2023
Giles Campion
Giles Campion
Director/Board Member 20-05-2020 01-04-2023
Chief Tech/Sci/R&D Officer 01-06-2019 01-04-2023
Jorgen Wittendorff
Jorgen Wittendorff
Corporate Officer/Principal 05-08-2019 06-02-2023
Eric Fink
Eric Fink
Human Resources Officer 01-02-2022 01-11-2022
Mark Rothera
Mark Rothera
Director/Board Member 14-09-2020 21-02-2022
Chief Executive Officer 14-09-2020 21-02-2022
President 14-09-2020 21-02-2022
Robert Quinn
Robert Quinn
Director of Finance/CFO 09-01-2019 06-01-2021
Corporate Secretary 09-01-2019 06-01-2021
Alison Gallafent
Alison Gallafent
Corporate Officer/Principal 01-02-2017 02-01-2020
David Solomon
David Solomon
Director/Board Member 20-08-2018 01-01-2020
Chief Executive Officer 20-08-2018 01-01-2020
Stephen Parker
Stephen Parker
Director/Board Member 16-10-2017 25-04-2019
Chairman 22-09-2015 16-10-2017
Independent Dir/Board Member 18-11-2013 25-04-2019
Andrew Richards
Andrew Richards
Director/Board Member 02-09-2016 20-08-2018
Chairman 20-08-2018 16-04-2019
Independent Dir/Board Member 02-09-2016 20-08-2018
David J. Ellam
David J. Ellam
Director/Board Member 18-07-2016 09-01-2019
Director of Finance/CFO 18-07-2016 09-01-2019
Corporate Secretary 18-07-2016 09-01-2019
Laura Roca-Alonso
Laura Roca-Alonso
Corporate Officer/Principal 01-01-2004 01-01-2019
Annalisa Jenkins
Annalisa Jenkins
Chief Executive Officer 04-06-2018 20-08-2018
Chairman 16-10-2017 20-08-2018
Torsten Hoffmann
Torsten Hoffmann
Chief Operating Officer 01-06-2017 21-06-2018
Ahmad Mortazavi
Ahmad Mortazavi
Director/Board Member 29-08-2012 04-06-2018
Chief Executive Officer 29-05-2013 04-06-2018
Corporate Officer/Principal 02-08-2012 29-05-2013
Lucio Iannone
Lucio Iannone
Corporate Officer/Principal 01-08-2014 30-09-2017
Michael Mulqueen
Michael Mulqueen
Corporate Officer/Principal 01-09-2017 -
Jörg Kaufmann
Jörg Kaufmann
Chief Tech/Sci/R&D Officer 06-05-2010 14-09-2016
Tim Freeborn
Tim Freeborn
Director/Board Member 08-10-2012 18-07-2016
Director of Finance/CFO 08-10-2012 18-07-2016
Corporate Secretary 08-10-2012 18-07-2016
Michael Khan
Michael Khan
Director/Board Member 19-09-2012 17-06-2016
Chief Tech/Sci/R&D Officer 19-09-2012 17-06-2016
Lars Guldbæk Karlsson
Lars Guldbæk Karlsson
Director/Board Member 05-01-2015 05-04-2016
Chief Tech/Sci/R&D Officer 05-01-2015 05-04-2016
Stuart J. M. Collinson
Stuart J. M. Collinson
Director/Board Member 18-01-2016 05-04-2016
Simon Sturge
Simon Sturge
Director/Board Member 21-08-2013 18-01-2016
Chairman 19-11-2013 05-01-2015
Independent Dir/Board Member 21-08-2013 18-01-2016
Alastair Riddell
Alastair Riddell
Director/Board Member 18-11-2013 05-01-2015
Chairman 18-11-2013 22-09-2015
Independent Dir/Board Member 18-11-2013 22-09-2015
Oliver von Stein
Oliver von Stein
Chief Operating Officer 01-09-2014 01-08-2015
Jia Huey Cheng
Jia Huey Cheng
Director/Board Member 29-05-2013 02-09-2014
Chief Operating Officer 19-11-2013 02-09-2014
Corporate Officer/Principal 29-05-2013 19-11-2013
Annie Cheng
Annie Cheng
Chief Operating Officer - 02-09-2014
Klaus Giese
Klaus Giese
Chief Tech/Sci/R&D Officer 23-11-2010 18-11-2013
Jeremy Randall
Jeremy Randall
Director/Board Member 01-07-2008 02-03-2010
Chairman 02-03-2010 18-11-2013
David Mack
David Mack
Director/Board Member 08-01-2010 26-06-2013
Anthony David Sedgwick
Anthony David Sedgwick
Director/Board Member 21-09-2011 29-05-2013
Chief Executive Officer 21-09-2011 29-05-2013
Max Herrmann
Max Herrmann
Director of Finance/CFO 02-08-2012 02-08-2012
Corporate Secretary 02-08-2012 02-08-2012
Annette Clancy
Annette Clancy
Director/Board Member 01-07-2008 02-08-2012
Georg Buchner
Georg Buchner
Corporate Officer/Principal 08-11-2011 01-06-2012
Thomas Christély
Thomas Christély
Chief Executive Officer 20-09-2011 10-02-2012
Chief Operating Officer - 20-09-2011
David C. U'Prichard
David C. U'Prichard
Director/Board Member 05-10-2009 31-12-2011
Philip Haworth
Philip Haworth
Director/Board Member 01-08-2011 01-08-2011
Chief Executive Officer 05-01-2010 01-08-2011
James Topper
James Topper
Director/Board Member 06-01-2010 29-07-2011
Xiao Dong Yang
Xiao Dong Yang
Corporate Officer/Principal 01-12-2009 01-05-2010
John Melvyn Davies
John Melvyn Davies
Director of Finance/CFO 01-01-1996 01-03-2010
Corporate Secretary 01-01-1996 01-03-2010
Bernd O. Wetzel
Bernd O. Wetzel
Director/Board Member 05-10-2009 05-01-2010
Jeremy Curnock-Cook
Jeremy Curnock-Cook
Director/Board Member 05-01-2010 05-01-2010
Independent Dir/Board Member 05-01-2010 -
Hugh Ronald Peter Reynolds
Hugh Ronald Peter Reynolds
Director/Board Member 05-01-2010 05-01-2010
Barbara Ruskin
Barbara Ruskin
General Counsel 01-03-2020 -
Corporate Officer/Principal - -
Michael Riley
Michael Riley
Corporate Officer/Principal 23-11-2010 -
Jeffery Scott Vick
Jeffery Scott Vick
Chief Executive Officer 27-07-2007 17-07-2008
Iain N. H. Rugheimer
Iain N. H. Rugheimer
Director/Board Member - 30-06-2008
Eric Boyle
Eric Boyle
Chairman 01-11-1994 01-05-2004
Founder 01-11-1994 01-05-2004
Rozi Morris
Rozi Morris
Public Communications Contact - -
John Mark Lucas
John Mark Lucas
General Counsel - -
Corporate Officer/Principal 05-10-2009 23-11-2010
David A. Kennard
David A. Kennard
Chief Operating Officer - -

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man 11
Vrouw 2

Waarvan leden van het uitvoerend comité

Man 6
Vrouw 2

Waarvan bestuurders

Man 5
Vrouw 0

Herzieningen

Herziening omzet 1 jaar
-
Herziening omzet 4 maanden
-
Herziening omzet 1 maanden
-
Herziening WPA 1 jaar
-
Herziening WPA 4 maanden
-
ESG MSCI
-
Logo Silence Therapeutics plc
Silence Therapeutics plc is een in het Verenigd Koninkrijk gevestigd biotechnologiebedrijf. De onderneming richt zich op het ontdekken en ontwikkelen van moleculen met kort interfererend ribonucleïnezuur (siRNA) om de expressie van doelgenen in de pathologie van ziekten met een onbeantwoorde medische behoefte te remmen. Haar siRNA-moleculen zijn ontworpen om het natuurlijke mechanisme van RNA-interferentie (RNAi) van het lichaam te benutten, door specifiek te binden aan en af te breken van boodschapper-RNA (mRNA), moleculen die coderen voor specifieke doelwit-ziekte-geassocieerde eiwitten in een cel. Het mRNAi GOLD-platform (GalNAc Oligonucleotide Discovery) van de onderneming is een platform van met precisie ontwikkelde geneesmiddelen, ontworpen om ziektegeassocieerde genen in de lever aan te pakken. Tot haar eigen productkandidaten behoren SLN360, voor de onbeantwoorde behoefte aan vermindering van het cardiovasculaire risico bij mensen met een hoog lipoproteïne (a)-gehalte, en SLN124, voor zeldzame hematologische aandoeningen, waaronder thalassemie, myelodysplastisch syndroom (MDS) en polycythemia vera (PV).
Werknemers
109
Meer informatie over het bedrijf

Sleutelfiguren die het bedrijf verlieten

Jeffery Scott Vick
-
Jeffery Scott Vick

Chief Executive Officer

27-07-2007 17-07-2008

Philip Haworth
-
Philip Haworth

Chief Executive Officer

05-01-2010 01-08-2011

Thomas Christély
-
Thomas Christély

Chief Executive Officer

20-09-2011 10-02-2012

Anthony David Sedgwick
-
Anthony David Sedgwick

Chief Executive Officer

21-09-2011 29-05-2013

Jeremy Randall
-
Jeremy Randall

Chairman

02-03-2010 18-11-2013

Alastair Riddell
-
Alastair Riddell

Chairman

18-11-2013 22-09-2015

Simon Sturge
-
Simon Sturge

Chairman

19-11-2013 05-01-2015

Ahmad Mortazavi
-
Ahmad Mortazavi

Chief Executive Officer

29-05-2013 04-06-2018

Annalisa Jenkins
-
Annalisa Jenkins

Chief Executive Officer

04-06-2018 20-08-2018

Andrew Richards
-
Andrew Richards

Chairman

20-08-2018 16-04-2019

Stephen Parker
-
Stephen Parker

Chairman

22-09-2015 16-10-2017

David Solomon
-
David Solomon

Chief Executive Officer

20-08-2018 01-01-2020

Mark Rothera
-
Mark Rothera

Chief Executive Officer

14-09-2020 21-02-2022